[Effectiveness of low dose Ara-C in acute nonlymphocytic leukemia and myelodysplastic syndromes--analysis of factors influencing the duration of responses, survival and clinical effects].
Sawada
H
H
Abe
T
T
Akasaka
K
K
Ishikura
H
H
Izumi
Y
Y
Inamoto
Y
Y
Usui
T
T
Okazaki
T
T
Okada
H
H
Katoh
Y
Y
D000208:Acute Disease; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy / Q000401:mortality; D012074:Remission Induction
D003561:Cytarabine